Q3 EPS Estimates for W. R. Berkley Lifted by Zacks Research

W. R. Berkley Co. (NYSE:WRB - Free Report) - Investment analysts at Zacks Research lifted their Q3 2026 EPS estimates for shares of W. R. Berkley in a note issued to investors on Monday, May 26th. Zacks Research analyst T. De now anticipates that the insurance provider will earn $1.14 per share for the quarter, up from their prior estimate of $1.08. The consensus estimate for W. R. Berkley's current full-year earnings is $4.33 per share. Zacks Research also issued estimates for W. R. Berkley's FY2026 earnings at $4.75 EPS, Q1 2027 earnings at $1.21 EPS and FY2027 earnings at $5.11 EPS.

A number of other brokerages also recently issued reports on WRB. UBS Group increased their price objective on shares of W. R. Berkley from $73.00 to $78.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. Wall Street Zen cut shares of W. R. Berkley from a "buy" rating to a "hold" rating in a research note on Wednesday, May 21st. Bank of America reissued a "neutral" rating and set a $74.00 price objective (up previously from $73.00) on shares of W. R. Berkley in a report on Tuesday, April 1st. Barclays boosted their price objective on W. R. Berkley from $52.00 to $62.00 and gave the stock an "underweight" rating in a research report on Friday, April 11th. Finally, Wells Fargo & Company increased their target price on W. R. Berkley from $69.00 to $70.00 and gave the company an "equal weight" rating in a research report on Tuesday, April 22nd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $70.64.

W. R. Berkley Price Performance

Shares of WRB stock traded up $0.68 during trading on Wednesday, hitting $74.64. The company had a trading volume of 4,276,324 shares, compared to its average volume of 1,771,001. The stock's 50-day moving average price is $70.32 and its 200 day moving average price is $64.05. The firm has a market capitalization of $28.32 billion, a P/E ratio of 17.11, a price-to-earnings-growth ratio of 1.56 and a beta of 0.44. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.36 and a current ratio of 0.36. W. R. Berkley has a one year low of $51.17 and a one year high of $76.38.

W. R. Berkley (NYSE:WRB - Get Free Report) last posted its quarterly earnings data on Monday, April 21st. The insurance provider reported $1.01 earnings per share for the quarter, missing the consensus estimate of $1.08 by ($0.07). The firm had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $3.01 billion. W. R. Berkley had a return on equity of 20.83% and a net margin of 12.88%.

Institutional Investors Weigh In On W. R. Berkley

Institutional investors have recently modified their holdings of the company. Optiver Holding B.V. boosted its position in W. R. Berkley by 107.3% during the fourth quarter. Optiver Holding B.V. now owns 427 shares of the insurance provider's stock valued at $25,000 after acquiring an additional 221 shares during the last quarter. Spectrum Wealth Counsel LLC bought a new stake in W. R. Berkley in the first quarter worth approximately $29,000. Garde Capital Inc. acquired a new position in W. R. Berkley in the first quarter valued at approximately $30,000. Whipplewood Advisors LLC bought a new position in shares of W. R. Berkley during the 4th quarter worth approximately $35,000. Finally, N.E.W. Advisory Services LLC bought a new stake in shares of W. R. Berkley in the 1st quarter valued at $36,000. 68.82% of the stock is owned by institutional investors.

About W. R. Berkley

W. R. Berkley Corporation, an insurance holding company, operates as a commercial lines writers worldwide. It operates in two segments, Insurance and Reinsurance & Monoline Excess. The Insurance segment underwrites commercial insurance business, including excess and surplus lines, admitted lines, and specialty personal lines.